Table 5.
Clinical outcomes of NSTEMI patients with atypical and typical symptoms in the propensity-matched cohort
| Clinical outcome | Patient with typical symptoms (n = 128) | Patient with atypical symptoms (n = 128) | p value |
|---|---|---|---|
| Composite of MACE | 26 (20.3) | 17 (13.3) | 0.132 |
| Cardiac death | 12 (9.4) | 7 (5.5) | 0.233 |
| All-cause death | 19 (14.8) | 9 (7.0) | 0.045 |
| Recurrent myocardial infarction | 4 (3.1) | 3 (2.3) | 0.702 |
| Any revascularization | 16 (12.5) | 16 (12.5) | 1.000 |
| Target lesion revascularization | 9 (7.0) | 10 (7.8) | 0.812 |
Values are presented as number (%).
NSTEMI, non-ST-segment elevation myocardial infarction; MACE, major adverse cardiac event.